Rituximab's cost for the treatment of primary cold agglutinin disease should not limit its use.
Delluc
Aurelien
A
aurelien.delluc@chu-brest.fr
Pasquier
Elisabeth
E
de Saint Martin
Luc
L
Mottier
Dominique
D
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000191:economics*; D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003362:Cost-Benefit Analysis; D006801:Humans; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab